Xuewen Zhang Selected Research

Pancreaticoduodenectomy

8/2019

Pancreatic reconstruction techniques after pancreaticoduodenectomy: a review of the literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuewen Zhang Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 08/2010
18	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2010
6	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2013
5	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2020 - 01/2019
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 07/2015
3	Glioma (Gliomas) 01/2018 - 09/2013
3	Carcinoma (Carcinomatosis) 01/2016 - 07/2014
2	Adenocarcinoma of Lung 01/2022 - 03/2021
2	Disease Progression 01/2021 - 07/2017
2	Carcinogenesis 01/2020 - 03/2016
2	Esophageal Squamous Cell Carcinoma 09/2019 - 01/2018
2	Pancreatic Fistula (Pancreatic Fistulas) 08/2019 - 02/2007
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 07/2017
2	Obesity 01/2018 - 01/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 02/2016 - 03/2014
1	Genomic Instability 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Hepatitis 01/2021
1	Infections 01/2021
1	Periapical Diseases 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2020
1	Lymphatic Metastasis 06/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Pituitary Neoplasms (Pituitary Adenoma) 06/2018
1	Medulloblastoma 06/2018
1	Dementia (Dementias) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Cognitive Dysfunction 01/2018
1	Epilepsy (Aura) 01/2018
1	Residual Neoplasm 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2017
1	Chronic Pain 01/2017
1	Cholangiocarcinoma 01/2017

Drug/Important Bio-Agent (IBA)

6	Long Noncoding RNAIBA 01/2022 - 01/2018
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2013
6	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2015
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
3	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 05/2014
3	Biological ProductsIBA 01/2021 - 12/2015
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
3	CateninsIBA 01/2020 - 06/2016
2	DNA (Deoxyribonucleic Acid)IBA 06/2020 - 05/2019
2	Indicators and Reagents (Reagents)IBA 09/2019 - 07/2014
2	Cisplatin (Platino)FDA LinkGeneric 05/2019 - 01/2017
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2018
2	Circular RNAIBA 01/2019 - 01/2019
2	VaccinesIBA 01/2019 - 07/2015
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2015
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 07/2017
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 07/2017
2	Insulin-Like Growth Factor I (IGF-1)IBA 02/2016 - 01/2013
2	BerberineIBA 09/2015 - 03/2014
2	Arachidonic Acid (Vitamin F)IBA 09/2015 - 08/2010
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2021
1	6-methyladenineIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021
1	IonsIBA 01/2021
1	Photosensitizing Agents (Photosensitizers)IBA 01/2021
1	OsteopontinIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 12/2020
1	Streptozocin (Streptozotocin)FDA Link 12/2020
1	Casein Kinase II (Casein Kinase 2)IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2020
1	MethyltransferasesIBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	alpha-L-Fucosidase (Fucosidase)IBA 09/2019
1	Cancer VaccinesIBA 01/2019
1	SolutionsIBA 01/2019
1	NucleotidesIBA 01/2019
1	Competitive Endogenous RNAIBA 01/2019
1	Combined VaccinesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 06/2018
1	Peptides (Polypeptides)IBA 06/2018
1	C-Reactive ProteinIBA 01/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018
1	AlbuminsIBA 01/2018
1	WD repeat containing planar cell polarity effectorIBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2017
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2017
1	ABT-737IBA 03/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017
1	Beclin-1IBA 03/2017
1	Antidepressive Agents (Antidepressants)IBA 01/2017

Therapy/Procedure

14	Therapeutics 01/2022 - 07/2014
4	Immunotherapy 01/2022 - 07/2015
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
1	Photothermal Therapy 01/2021
1	Photochemotherapy (Photodynamic Therapy) 01/2021
1	Radiotherapy 01/2021
1	Pancreaticoduodenectomy 08/2019
1	Aftercare (After-Treatment) 01/2019
1	Lymph Node Excision (Lymph Node Dissection) 01/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Intravenous Administration 03/2017